Beam Therapeutics appoints Chirfi Guindo to board of directors

Beam Therapeutics Inc.

Chirfi Guindo, chief marketing officer of Human Health at Merck, appointed to Beam's board.
Board expanded from seven to eight members; Guindo elected as Class I director effective Dec. 2, 2024.
Guindo brings 25+ years at Merck and Biogen, expertise in global strategy and commercial operations.
He will serve on the Compensation Committee of the board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.